ASXL1 and myelodysplastic syndrome: Comparative structural and biochemical analyses of full-length ASXL1 and truncated cancer-associated ASXL1 mutations could shed light on their functional consequences and the molecular mechanisms underlying ASXL1 mutations in MDS and AML.